Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
11.50
+0.26 (2.31%)
At close: May 26, 2026, 4:00 PM EDT
11.52
+0.02 (0.17%)
After-hours: May 26, 2026, 7:23 PM EDT
Erasca Employees
Erasca had 103 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
103
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,689,515
Market Cap
3.58B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 0 | - |
| Dec 31, 2024 | 103 | -23 | -18.25% |
| Dec 31, 2023 | 126 | -3 | -2.33% |
| Dec 31, 2022 | 129 | 6 | 4.88% |
| Dec 31, 2021 | 123 | 21 | 20.59% |
| Jun 30, 2021 | 102 | - | - |
| Mar 31, 2021 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Crinetics Pharmaceuticals | 594 |
| Denali Therapeutics | 507 |
| Travere Therapeutics | 497 |
| Relay Therapeutics | 193 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 154 |
ERAS News
- 10 days ago - Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference - MarketBeat
- 13 days ago - Erasca Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 14 days ago - Erasca price target lowered to $26 from $28 at Mizuho - TheFly
- 15 days ago - Erasca reports Q1 EPS (60c), consensus (23c) - TheFly
- 15 days ago - Erasca Reports First Quarter 2026 Business Updates and Financial Results - GlobeNewsWire
- 15 days ago - Erasca Earnings release: Q1 2026 - Filings
- 15 days ago - Erasca Quarterly report: Q1 2026 - Filings
- 15 days ago - Erasca enters AURORAS-1 clinical trial pact, supply agreement with Merck - TheFly